Broadview Ventures

company

About

Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.

  • 1 - 10

Details

Industries
Health Diagnostics,Life Science,Medical Device,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.

The Foundation Leducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.

With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Investments

Number of Investments
Number of Lead Investments
2
1
Broadview Ventures has made 2 investments. Their most recent investment was on Dec 8, 2022, when Cardiosense raised $15.10M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 8, 2022 Cardiosense
Series A $15.10M Artificial Intelligence Yes
Jun 26, 2017 Adient Medical
Debt Financing $1.20M Biotechnology